<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01811316</url>
  </required_header>
  <id_info>
    <org_study_id>CLP-2013-1-23</org_study_id>
    <nct_id>NCT01811316</nct_id>
  </id_info>
  <brief_title>A Clinical Trial to Evaluate Long-term Efficacy and Safety of Lozenges Containing Lactobacilli Reuteri (Prodentis™) on Gingivitis</brief_title>
  <official_title>A Clinical Trial to Evaluate Long-term Efficacy and Safety of Lozenges Containing Lactobacilli Reuteri (Prodentis™) on Gingivitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunstar Americas</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunstar Americas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the long-term efficacy and safety of lozenges
      containing probiotics in reducing gingivitis. The primary purpose of this study is to support
      claims from U.S. instructions for use (IFU) for GUM® PerioBalance®.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Modified Gingival Index (MGI)</measure>
    <time_frame>4, 12 and 24 weeks</time_frame>
    <description>Modified Gingival Index (MGI) (Lobene, Weatherford et al. 1986) was measured on six gingival areas of all scorable teeth, using a scale of 0-4 as follows: Scores Criteria 0 Normal (absence of inflammation)
Mild inflammation (slight change of color, little change in texture) of any portion of, but not the entire marginal or papillary gingival unit
Mild inflammation of the entire gingival unit
Moderate inflammation (moderate glazing, redness, edema and/or hypertrophy) of the marginal or papillary gingival unit
Severe inflammation (marked redness and edema/hyper-trophy, spontaneous bleeding or ulceration) of the marginal or papillary gingival unit.
Whole mouth MGI scores were calculated by summing all scores and dividing by the number of examined scorable sites.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Bleeding on Probing (BOP)</measure>
    <time_frame>4, 12 and 24 weeks</time_frame>
    <description>Bleeding on probing was assessed 30 seconds after probing. A dichotomous scoring system was used at six sites per tooth using one (1) and zero (0) for presence or absence, respectively. BOP (%) is a percentage of sites BOP.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Plaque Index (PI)</measure>
    <time_frame>4, 12 and 24 weeks</time_frame>
    <description>Plaque Index of Turesky Modification of Quigley-Hein (Turesky, Gilmore et al. 1970) (PI) was scored on all natural teeth (except third molars) after disclosing with erythrosine solution. Scores Criteria:
0 No plaque
Separate flecks of plaque at the cervical margin of the tooth
A thin continuous band of plaque (up to one mm) at the cervical margin of the tooth
A band of plaque wider than one mm but covering less than one-third of the crown of the tooth
Plaque covering at least one-third but less than two-thirds of the crown of the tooth
Plaque covering two-thirds or more of the crown of the tooth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Probing Depth (PD)</measure>
    <time_frame>4, 12 and 24 weeks</time_frame>
    <description>Periodontal pocket depth (PD) was determined with a periodontal probe at six sites per tooth rounded to the next lower whole mm.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change From Baseline in Inflammatory Markers in Gingival Crevicular</measure>
    <time_frame>15 days, 4, 12 and 24 weeks</time_frame>
    <description>Gingival Crevicular Fluid (GCF) samples will be analyzed for inflammatory cytokines/chemokines and matrix metalloproteases using multiplexing ELISA.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Gingivitis</condition>
  <arm_group>
    <arm_group_label>Probiotics Lozenge (twice a day)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects take their lozenge twice a day, one lozenge in the morning after brushing and one lozenge in the evening after brushing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotics Lozenge (once a day)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Lozenge (once a day)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Probiotics</intervention_name>
    <arm_group_label>Probiotics Lozenge (twice a day)</arm_group_label>
    <arm_group_label>Probiotics Lozenge (once a day)</arm_group_label>
    <arm_group_label>Placebo Lozenge (once a day)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willing and able to read, understand and sign an Informed Consent form.

          -  Good general health as evidenced by the medical history.

          -  Between 18 and 65 years of age.

          -  Male or female.

          -  Minimum of 20 teeth, excluding crowns and third molar teeth.

          -  Mean whole mouth Modified Gingival Index of greater-than or equal to 2.0 at baseline.

          -  Willing to abstain from all oral hygiene procedures for 12-18 hours prior to clinical
             visits.

          -  Willing to abstain from eating and drinking in the morning of visits, only drinking
             water is allowed.

          -  Willing to abstain from interdental cleaning, chewing gums, oral whitening, mouth
             rinse and tobacco products for the study duration.

          -  Able to understand and follow study directions.

          -  No known history of allergy to dairy products or their ingredients, relevant to any
             ingredient in the test products as determined by the dental/medical professional
             monitoring the study.

        Exclusion Criteria

          -  Presence of orthodontic appliances.

          -  Intra-oral soft tissue lesions due to pathology or trauma

          -  Patients with aggressive periodontitis, acute necrotizing ulcerative gingivitis, or
             gross decay at discretion of PI.

          -  More than two sites with pocket depth &gt;5mm and concomitant attachment loss of &gt;2mm.

          -  Pregnant or lactating females or females of child bearing potential not using
             acceptable methods of birth control (hormonal, barriers or abstinence).

          -  Use of antibiotics within 3 months of enrollment

          -  History of drug use that is associated with gum overgrowth (i.e., Dilantin,
             nifedipine, etc)

          -  Chronic use of medication such as steroids, NSAIDs (more than 2-3 days/week),
             anti-coagulant medications, immunosuppressant medications or any other medications
             that in the opinion of the Investigator would interfere with the evaluation or
             confound interpretation of the study results. Use of low dose of acetylsalicylic acid
             (81 mg) is permitted.

          -  Unwilling to sign a confidentiality statement and/or return the test products.

          -  Medical condition which requires pre-medication prior to dental visits/procedures.

          -  Immune compromised individuals (HIV, AIDS, immunosuppressive drug therapy).

          -  Current use of probiotics or probiotic containing food (i.e., yogurt)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hatice Hasturk, DDS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Forsyth Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Forsyth Institute</name>
      <address>
        <city>Cambridge</city>
        <state>Massachusetts</state>
        <zip>02142</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2013</study_first_submitted>
  <study_first_submitted_qc>March 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2013</study_first_posted>
  <results_first_submitted>May 17, 2017</results_first_submitted>
  <results_first_submitted_qc>May 17, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">October 9, 2017</results_first_posted>
  <last_update_submitted>November 3, 2017</last_update_submitted>
  <last_update_submitted_qc>November 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingivitis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Probiotics Lozenge (Twice a Day)</title>
          <description>Subjects take their lozenge twice a day, one lozenge in the morning after brushing and one lozenge in the evening after brushing.</description>
        </group>
        <group group_id="P2">
          <title>Probiotics Lozenge (Once a Day)</title>
          <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
        </group>
        <group group_id="P3">
          <title>Placebo Lozenge (Once a Day)</title>
          <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Visit 4 Weeks</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Visit 12 Weeks</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Probiotics Lozenge (Twice a Day)</title>
          <description>Subjects take their lozenge twice a day, one lozenge in the morning after brushing and one lozenge in the evening after brushing.</description>
        </group>
        <group group_id="B2">
          <title>Probiotics Lozenge (Once a Day)</title>
          <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
        </group>
        <group group_id="B3">
          <title>Placebo Lozenge (Once a Day)</title>
          <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="22"/>
            <count group_id="B3" value="19"/>
            <count group_id="B4" value="62"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Year</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40" spread="13"/>
                    <measurement group_id="B2" value="44" spread="15"/>
                    <measurement group_id="B3" value="34" spread="11"/>
                    <measurement group_id="B4" value="40" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="59"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Modified Gingival Index (MGI)</title>
        <description>Modified Gingival Index (MGI) (Lobene, Weatherford et al. 1986) was measured on six gingival areas of all scorable teeth, using a scale of 0-4 as follows: Scores Criteria 0 Normal (absence of inflammation)
Mild inflammation (slight change of color, little change in texture) of any portion of, but not the entire marginal or papillary gingival unit
Mild inflammation of the entire gingival unit
Moderate inflammation (moderate glazing, redness, edema and/or hypertrophy) of the marginal or papillary gingival unit
Severe inflammation (marked redness and edema/hyper-trophy, spontaneous bleeding or ulceration) of the marginal or papillary gingival unit.
Whole mouth MGI scores were calculated by summing all scores and dividing by the number of examined scorable sites.</description>
        <time_frame>4, 12 and 24 weeks</time_frame>
        <population>One subject was lost to follow up between 4 and 12 weeks.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotics Lozenge (Twice a Day)</title>
            <description>Subjects take their lozenge twice a day, one lozenge in the morning after brushing and one lozenge in the evening after brushing.</description>
          </group>
          <group group_id="O2">
            <title>Probiotics Lozenge (Once a Day)</title>
            <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
          </group>
          <group group_id="O3">
            <title>Placebo Lozenge (Once a Day)</title>
            <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Modified Gingival Index (MGI)</title>
          <description>Modified Gingival Index (MGI) (Lobene, Weatherford et al. 1986) was measured on six gingival areas of all scorable teeth, using a scale of 0-4 as follows: Scores Criteria 0 Normal (absence of inflammation)
Mild inflammation (slight change of color, little change in texture) of any portion of, but not the entire marginal or papillary gingival unit
Mild inflammation of the entire gingival unit
Moderate inflammation (moderate glazing, redness, edema and/or hypertrophy) of the marginal or papillary gingival unit
Severe inflammation (marked redness and edema/hyper-trophy, spontaneous bleeding or ulceration) of the marginal or papillary gingival unit.
Whole mouth MGI scores were calculated by summing all scores and dividing by the number of examined scorable sites.</description>
          <population>One subject was lost to follow up between 4 and 12 weeks.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>4 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.07" spread="0.12"/>
                    <measurement group_id="O2" value="-0.09" spread="0.12"/>
                    <measurement group_id="O3" value="-0.09" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.11"/>
                    <measurement group_id="O2" value="-0.02" spread="0.12"/>
                    <measurement group_id="O3" value="-0.04" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.13"/>
                    <measurement group_id="O2" value="-0.04" spread="0.13"/>
                    <measurement group_id="O3" value="-0.06" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Bleeding on Probing (BOP)</title>
        <description>Bleeding on probing was assessed 30 seconds after probing. A dichotomous scoring system was used at six sites per tooth using one (1) and zero (0) for presence or absence, respectively. BOP (%) is a percentage of sites BOP.</description>
        <time_frame>4, 12 and 24 weeks</time_frame>
        <population>One subject was lost to follow up between 4 and 12 weeks.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotics Lozenge (Twice a Day)</title>
            <description>Subjects take their lozenge twice a day, one lozenge in the morning after brushing and one lozenge in the evening after brushing.</description>
          </group>
          <group group_id="O2">
            <title>Probiotics Lozenge (Once a Day)</title>
            <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
          </group>
          <group group_id="O3">
            <title>Placebo Lozenge (Once a Day)</title>
            <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Bleeding on Probing (BOP)</title>
          <description>Bleeding on probing was assessed 30 seconds after probing. A dichotomous scoring system was used at six sites per tooth using one (1) and zero (0) for presence or absence, respectively. BOP (%) is a percentage of sites BOP.</description>
          <population>One subject was lost to follow up between 4 and 12 weeks.</population>
          <units>percentage of sites BOP</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>4 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.2" spread="13.8"/>
                    <measurement group_id="O2" value="-1.8" spread="10.7"/>
                    <measurement group_id="O3" value="-3.0" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.6" spread="14.9"/>
                    <measurement group_id="O2" value="0.8" spread="13.5"/>
                    <measurement group_id="O3" value="2.9" spread="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.3" spread="17.1"/>
                    <measurement group_id="O2" value="5.6" spread="17.9"/>
                    <measurement group_id="O3" value="3.5" spread="14.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Plaque Index (PI)</title>
        <description>Plaque Index of Turesky Modification of Quigley-Hein (Turesky, Gilmore et al. 1970) (PI) was scored on all natural teeth (except third molars) after disclosing with erythrosine solution. Scores Criteria:
0 No plaque
Separate flecks of plaque at the cervical margin of the tooth
A thin continuous band of plaque (up to one mm) at the cervical margin of the tooth
A band of plaque wider than one mm but covering less than one-third of the crown of the tooth
Plaque covering at least one-third but less than two-thirds of the crown of the tooth
Plaque covering two-thirds or more of the crown of the tooth</description>
        <time_frame>4, 12 and 24 weeks</time_frame>
        <population>One subject was lost to follow up between 4 and 12 weeks.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotics Lozenge (Twice a Day)</title>
            <description>Subjects take their lozenge twice a day, one lozenge in the morning after brushing and one lozenge in the evening after brushing.</description>
          </group>
          <group group_id="O2">
            <title>Probiotics Lozenge (Once a Day)</title>
            <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
          </group>
          <group group_id="O3">
            <title>Placebo Lozenge (Once a Day)</title>
            <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Plaque Index (PI)</title>
          <description>Plaque Index of Turesky Modification of Quigley-Hein (Turesky, Gilmore et al. 1970) (PI) was scored on all natural teeth (except third molars) after disclosing with erythrosine solution. Scores Criteria:
0 No plaque
Separate flecks of plaque at the cervical margin of the tooth
A thin continuous band of plaque (up to one mm) at the cervical margin of the tooth
A band of plaque wider than one mm but covering less than one-third of the crown of the tooth
Plaque covering at least one-third but less than two-thirds of the crown of the tooth
Plaque covering two-thirds or more of the crown of the tooth</description>
          <population>One subject was lost to follow up between 4 and 12 weeks.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>4 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.36"/>
                    <measurement group_id="O2" value="0.06" spread="0.28"/>
                    <measurement group_id="O3" value="0.08" spread="0.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.18" spread="0.35"/>
                    <measurement group_id="O2" value="0.06" spread="0.4"/>
                    <measurement group_id="O3" value="0.00" spread="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="18"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" spread="0.44"/>
                    <measurement group_id="O2" value="0.11" spread="0.39"/>
                    <measurement group_id="O3" value="0.03" spread="0.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Probing Depth (PD)</title>
        <description>Periodontal pocket depth (PD) was determined with a periodontal probe at six sites per tooth rounded to the next lower whole mm.</description>
        <time_frame>4, 12 and 24 weeks</time_frame>
        <population>One subject was lost to follow up between 4 and 12 weeks.</population>
        <group_list>
          <group group_id="O1">
            <title>Probiotics Lozenge (Twice a Day)</title>
            <description>Subjects take their lozenge twice a day, one lozenge in the morning after brushing and one lozenge in the evening after brushing.</description>
          </group>
          <group group_id="O2">
            <title>Probiotics Lozenge (Once a Day)</title>
            <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
          </group>
          <group group_id="O3">
            <title>Placebo Lozenge (Once a Day)</title>
            <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Probing Depth (PD)</title>
          <description>Periodontal pocket depth (PD) was determined with a periodontal probe at six sites per tooth rounded to the next lower whole mm.</description>
          <population>One subject was lost to follow up between 4 and 12 weeks.</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>4 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.11"/>
                    <measurement group_id="O2" value="0.00" spread="0.13"/>
                    <measurement group_id="O3" value="0.02" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.12"/>
                    <measurement group_id="O2" value="0.03" spread="0.12"/>
                    <measurement group_id="O3" value="0.10" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="22"/>
                    <count group_id="O3" value="19"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.11"/>
                    <measurement group_id="O2" value="0.08" spread="0.15"/>
                    <measurement group_id="O3" value="0.11" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Change From Baseline in Inflammatory Markers in Gingival Crevicular</title>
        <description>Gingival Crevicular Fluid (GCF) samples will be analyzed for inflammatory cytokines/chemokines and matrix metalloproteases using multiplexing ELISA.</description>
        <time_frame>15 days, 4, 12 and 24 weeks</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse Event data were collected at each visit over 24 weeks after randomization.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Probiotics Lozenge (Twice a Day)</title>
          <description>Subjects take their lozenge twice a day, one lozenge in the morning after brushing and one lozenge in the evening after brushing.</description>
        </group>
        <group group_id="E2">
          <title>Probiotics Lozenge (Once a Day)</title>
          <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
        </group>
        <group group_id="E3">
          <title>Placebo Lozenge (Once a Day)</title>
          <description>Subjects take their lozenge once a day, one lozenge at night after brushing.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic sinustis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cold</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Sore throat</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review. PI shall delay publications for up to 90 days upon receipt of a written request from the sponsor in order to allow the sponsor to register intellectual property rights that are included in the proposed publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Akane Takemura</name_or_title>
      <organization>Sunstar Americas, Inc.</organization>
      <phone>+1-847-794-4276</phone>
      <email>akane.takemura@us.sunstar.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

